USANA Health Sciences, Inc. USNA

14.50 0.24 1.68% as of 25 Sep

Market cap: $263.5M
P/E: 0.0×

Follow USNA

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
Revenue	925.26	854.50	921.01	998.60	1,186.46	1,134.64	1,060.90	1,189.25	1,047.27	1,006.08
Revenue Growth	8.28%	(7.22%)	(7.77%)	(15.83%)	4.57%	6.95%	(10.79%)	13.56%	4.09%	9.54%
Cost of Revenue	200.85	161.21	176.69	193.89	217.90	209.11	187.50	200.71	179.40	180.19
Gross Profit	724.41	693.29	744.32	804.71	968.57	925.53	873.40	988.54	867.86	825.89
SG&A Expenses	680.01	626.97	651.25	697.10	798.37	749.04	727.21	800.19	735.36	687.27
Operating Income	37.43	66.32	93.07	107.61	170.19	176.49	146.19	188.35	132.50	138.62
Non-operating Income/Expense	4.10	10.03	9.38	1.01	0.45	1.46	4.31	3.16	2.14	(0.07)
Non-operating Interest Expenses	0.84	0.28	0.26	0.19	0.06	0.51	0.07	0.04	0.05	0.44
EBT	41.53	76.35	102.45	108.62	170.64	177.95	150.50	191.51	134.64	138.55
Income Tax Provision	30.05	34.29	38.67	39.27	54.14	53.28	49.97	65.29	72.11	38.51
Income after Tax	11.48	42.06	63.79	69.35	116.51	124.66	100.53	126.22	62.54	100.04
Dividends (Preferred)	—	0.00	0.00	0.00	0.00	0.00	—	0.00	0.00	—
Non-Controlling Interest	0.72	0.03	—	—	—	—	—	—	—	—
Net Income Common	10.76	42.03	63.79	69.35	116.51	124.66	100.53	126.22	62.54	100.04
EPS (Basic)	0.58	2.19	3.30	3.59	5.73	5.86	4.41	5.12	2.53	3.99
EPS (Diluted)	0.58	2.19	3.30	3.59	5.73	5.86	4.41	5.12	2.53	3.99
Shares (Basic, Weighted)	18.54	19.10	19.25	19.25	20.15	21.16	22.64	24.11	24.35	24.19
Shares (Diluted, Weighted)	18.57	19.16	19.35	19.31	20.34	21.26	22.82	24.64	24.71	25.05
Gross Margin	78.29%	81.13%	80.82%	80.58%	81.63%	81.57%	82.33%	83.12%	82.87%	82.09%
EBIT Margin	4.05%	7.76%	10.11%	10.78%	14.34%	15.55%	13.78%	15.84%	12.65%	13.78%
EBT margin	4.49%	8.94%	11.12%	10.88%	14.38%	15.68%	14.19%	16.10%	12.86%	13.77%
Net Profit Margin	1.16%	4.92%	6.93%	6.94%	9.82%	10.99%	9.48%	10.61%	5.97%	9.94%
Free Cash Flow Margin	1.34%	5.97%	6.10%	9.36%	9.14%	12.81%	10.39%	11.86%	10.56%	10.36%
EBITDA	77.13	88.55	113.47	129.02	192.38	199.00	169.20	205.20	148.61	152.10
EBIT	37.43	66.32	93.07	107.61	170.19	176.49	146.19	188.35	132.50	138.62
Income from Continuous Operations	11.48	42.06	63.79	69.35	116.51	124.66	100.53	126.22	62.54	100.04
Consolidated Net Income/Loss	11.48	42.06	63.79	69.35	116.51	124.66	100.53	126.22	62.54	100.04
EPS (Basic, from Continuous Ops)	0.62	2.20	3.31	3.60	5.78	5.89	4.44	5.24	2.57	4.14
EPS (Basic, Consolidated)	0.62	2.20	3.31	3.60	5.78	5.89	4.44	5.24	2.57	4.14
EPS (Diluted, from Cont. Ops)	0.62	2.20	3.30	3.59	5.73	5.86	4.41	5.12	2.53	3.99
Shares (Diluted, Average)	18.57	19.16	19.35	19.31	20.34	21.26	22.82	24.64	24.71	25.05
EPS (Diluted, Consolidated)	0.62	2.20	3.30	3.59	5.73	5.86	4.41	5.12	2.53	3.99
EBITDA Margin	8.34%	10.36%	12.32%	12.92%	16.21%	17.54%	15.95%	17.25%	14.19%	15.12%
Operating Cash Flow Margin	2.42%	7.14%	7.67%	10.40%	10.22%	14.14%	11.95%	12.79%	11.82%	13.61%

Show all line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

USANA Health Sciences, Inc. USNA